Neuromonitoring Devices Market By Product (Intracranial Pressure Monitoring, Cerebral Oximeter, Near Infrared Spectroscopy, Speckle Imaging, Doppler Ultrasound, EEG, Fetal/Neonatal Neuro-Monitoring Devices, Micro Ultrasound, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
The global neuromonitoring devices market was valued at $5,593.1 million in 2021 and is projected to reach $10,276 million by 2030, growing at a CAGR of 7.24% from 2022 to 2030.
Rising demand for non-invasive and minimally invasive medical devices is expected to drive the global nuromonitoring devices market. Because it includes intervention with sensitive brain tissue, intrusive tracking is a complex, distressing, and dangerous procedure. As a result, both patients and doctors prefer the use of non-invasive or non-invasive nuromonitoring devices. Because of their advantages, non-invasive ICP monitoring systems, computed tomography devices, tympanic displacement procedures, nervous system sheath diameter, chest x ray, and fundoscopy have seen a rapid upsurge, compelling market participants to grow and commercialize such products. All such factors are expected to drive the neuromonitoring devices market during the forecast period.
The market for neuromonitoring devices is likely to face some major hindrance due to high cost of the devices. Neuromonitoring devices are highly expensive due to the use of many costly equipment such as advanced sensors, electrodes, and wirings used for their construction. Also, less availability of skilled personnel to operate such devices is further anticipated to impede the market growth.
To meet the rising demand for advanced neuromonitoring devices, key market players are constantly innovating their portfolio of neuromonitoring devices. For this reason, companies have begun to invest heavily in advancing their research and development activities and developing new and advanced product lines.
The global neuromonitoring devices market is segmented on the basis of product and region. By product, the market is classified into intracranial pressure monitoring, cerebral oximeter, near infrared spectroscopy, speckle imaging, doppler ultrasound, EEG, fetal/neonatal neuromonitoring devices, micro ultrasound, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players profiled in this report include GE Healthcare, Koninklijke Philips N.V., Medtronic Plc, Nihon Kohden Corporation, Natus Medical Incorporated., Nuvasive, Inc., Advanced Brain Monitoring, Inc., Intranerve Neuroscience Holdings, Llc, Specialtycare, and RIMED Ltd.
KEY MARKET SEGMENTS
By Product
Intracranial Pressure Monitoring
Cerebral Oximeter
Near Infrared Spectroscopy
Speckle Imaging
Doppler Ultrasound
EEG
Fetal/Neonatal Neuromonitoring devices
Micro Ultrasound
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
GE Healthcare
Koninklijke Philips N.V.
Medtronic Plc
Nihon Kohden Corporation
Natus Medical Incorporated
Nuvasive, Inc.
Advanced Brain Monitoring, Inc.
Intranerve Neuroscience Holdings, LLC
Specialtycare
RIMED Ltd.
Key Market Segments
By Product
Intracranial Pressure Monitoring
Cerebral Oximeter
Near Infrared Spectroscopy
Speckle Imaging
Doppler Ultrasound
EEG
Fetal/Neonatal Neuro-Monitoring Devices
Micro Ultrasound
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest Of Asia Pacific
LAMEA
Brazil
Saudi Arabia
UAE
South Africa
Rest of LAMEA
Key Market Players
Koninklijke Philips N.V.
Nihon Kohden Corporation
Natus Medical Incorporated
Medtronic Plc
GE Healthcare
Nuvasive, Inc.
Advanced Brain Monitoring, Inc.
Intranerve Neuroscience Holdings, LLC
RIMED Ltd.
SpecialtyCare
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Regulatory Guidelines
- 3.8.Value Chain Analysis
- 3.9.Market Share Analysis
- 3.10.Key Regulation Analysis
- 3.11.Patent Landscape
- CHAPTER 4: NEUROMONITORING DEVICES MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Intracranial Pressure Monitoring
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Cerebral Oximeter
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Near Infrared Spectroscopy
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- 4.5 Speckle Imaging
- 4.5.1 Key market trends, growth factors and opportunities
- 4.5.2 Market size and forecast, by region
- 4.5.3 Market analysis by country
- 4.6 Doppler Ultrasound
- 4.6.1 Key market trends, growth factors and opportunities
- 4.6.2 Market size and forecast, by region
- 4.6.3 Market analysis by country
- 4.7 EEG
- 4.7.1 Key market trends, growth factors and opportunities
- 4.7.2 Market size and forecast, by region
- 4.7.3 Market analysis by country
- 4.8 Fetal/Neonatal Neuro-Monitoring Devices
- 4.8.1 Key market trends, growth factors and opportunities
- 4.8.2 Market size and forecast, by region
- 4.8.3 Market analysis by country
- 4.9 Micro Ultrasound
- 4.9.1 Key market trends, growth factors and opportunities
- 4.9.2 Market size and forecast, by region
- 4.9.3 Market analysis by country
- 5.0 Others
- 5.0.1 Key market trends, growth factors and opportunities
- 5.0.2 Market size and forecast, by region
- 5.0.3 Market analysis by country
- CHAPTER 5: NEUROMONITORING DEVICES MARKET, BY REGION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 North America
- 5.2.1 Key trends and opportunities
- 5.2.2 North America Market size and forecast, by Product
- 5.2.3 North America Market size and forecast, by country
- 5.2.3.1 U.S.
- 5.2.3.1.1 Market size and forecast, by Product
- 5.2.3.2 Canada
- 5.2.3.2.1 Market size and forecast, by Product
- 5.2.3.3 Mexico
- 5.2.3.3.1 Market size and forecast, by Product
- 5.3 Europe
- 5.3.1 Key trends and opportunities
- 5.3.2 Europe Market size and forecast, by Product
- 5.3.3 Europe Market size and forecast, by country
- 5.3.3.1 Germany
- 5.3.3.1.1 Market size and forecast, by Product
- 5.3.3.2 United Kingdom
- 5.3.3.2.1 Market size and forecast, by Product
- 5.3.3.3 France
- 5.3.3.3.1 Market size and forecast, by Product
- 5.3.3.4 Spain
- 5.3.3.4.1 Market size and forecast, by Product
- 5.3.3.5 Italy
- 5.3.3.5.1 Market size and forecast, by Product
- 5.3.3.6 Rest of Europe
- 5.3.3.6.1 Market size and forecast, by Product
- 5.4 Asia-Pacific
- 5.4.1 Key trends and opportunities
- 5.4.2 Asia-Pacific Market size and forecast, by Product
- 5.4.3 Asia-Pacific Market size and forecast, by country
- 5.4.3.1 China
- 5.4.3.1.1 Market size and forecast, by Product
- 5.4.3.2 Japan
- 5.4.3.2.1 Market size and forecast, by Product
- 5.4.3.3 India
- 5.4.3.3.1 Market size and forecast, by Product
- 5.4.3.4 South Korea
- 5.4.3.4.1 Market size and forecast, by Product
- 5.4.3.5 Australia
- 5.4.3.5.1 Market size and forecast, by Product
- 5.4.3.6 Rest Of Asia Pacific
- 5.4.3.6.1 Market size and forecast, by Product
- 5.5 LAMEA
- 5.5.1 Key trends and opportunities
- 5.5.2 LAMEA Market size and forecast, by Product
- 5.5.3 LAMEA Market size and forecast, by country
- 5.5.3.1 Brazil
- 5.5.3.1.1 Market size and forecast, by Product
- 5.5.3.2 Saudi Arabia
- 5.5.3.2.1 Market size and forecast, by Product
- 5.5.3.3 UAE
- 5.5.3.3.1 Market size and forecast, by Product
- 5.5.3.4 South Africa
- 5.5.3.4.1 Market size and forecast, by Product
- 5.5.3.5 Rest of LAMEA
- 5.5.3.5.1 Market size and forecast, by Product
- CHAPTER 6: COMPANY LANDSCAPE
- 6.1. Introduction
- 6.2. Top winning strategies
- 6.3. Product Mapping of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Key developments
- CHAPTER 7: COMPANY PROFILES
- 7.1 Koninklijke Philips N.V.
- 7.1.1 Company overview
- 7.1.2 Company snapshot
- 7.1.3 Operating business segments
- 7.1.4 Product portfolio
- 7.1.5 Business performance
- 7.1.6 Key strategic moves and developments
- 7.2 Nihon Kohden Corporation
- 7.2.1 Company overview
- 7.2.2 Company snapshot
- 7.2.3 Operating business segments
- 7.2.4 Product portfolio
- 7.2.5 Business performance
- 7.2.6 Key strategic moves and developments
- 7.3 Natus Medical Incorporated
- 7.3.1 Company overview
- 7.3.2 Company snapshot
- 7.3.3 Operating business segments
- 7.3.4 Product portfolio
- 7.3.5 Business performance
- 7.3.6 Key strategic moves and developments
- 7.4 Medtronic Plc
- 7.4.1 Company overview
- 7.4.2 Company snapshot
- 7.4.3 Operating business segments
- 7.4.4 Product portfolio
- 7.4.5 Business performance
- 7.4.6 Key strategic moves and developments
- 7.5 GE Healthcare
- 7.5.1 Company overview
- 7.5.2 Company snapshot
- 7.5.3 Operating business segments
- 7.5.4 Product portfolio
- 7.5.5 Business performance
- 7.5.6 Key strategic moves and developments
- 7.6 Nuvasive, Inc.
- 7.6.1 Company overview
- 7.6.2 Company snapshot
- 7.6.3 Operating business segments
- 7.6.4 Product portfolio
- 7.6.5 Business performance
- 7.6.6 Key strategic moves and developments
- 7.7 Advanced Brain Monitoring, Inc.
- 7.7.1 Company overview
- 7.7.2 Company snapshot
- 7.7.3 Operating business segments
- 7.7.4 Product portfolio
- 7.7.5 Business performance
- 7.7.6 Key strategic moves and developments
- 7.8 Intranerve Neuroscience Holdings, LLC
- 7.8.1 Company overview
- 7.8.2 Company snapshot
- 7.8.3 Operating business segments
- 7.8.4 Product portfolio
- 7.8.5 Business performance
- 7.8.6 Key strategic moves and developments
- 7.9 RIMED Ltd.
- 7.9.1 Company overview
- 7.9.2 Company snapshot
- 7.9.3 Operating business segments
- 7.9.4 Product portfolio
- 7.9.5 Business performance
- 7.9.6 Key strategic moves and developments
- 7.10 SpecialtyCare
- 7.10.1 Company overview
- 7.10.2 Company snapshot
- 7.10.3 Operating business segments
- 7.10.4 Product portfolio
- 7.10.5 Business performance
- 7.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 2. NEUROMONITORING DEVICES MARKET SIZE, FOR INTRACRANIAL PRESSURE MONITORING, BY REGION, 2021-2030 ($MILLION)
- TABLE 3. NEUROMONITORING DEVICES MARKET FOR INTRACRANIAL PRESSURE MONITORING, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 4. NEUROMONITORING DEVICES MARKET SIZE, FOR CEREBRAL OXIMETER, BY REGION, 2021-2030 ($MILLION)
- TABLE 5. NEUROMONITORING DEVICES MARKET FOR CEREBRAL OXIMETER, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 6. NEUROMONITORING DEVICES MARKET SIZE, FOR NEAR INFRARED SPECTROSCOPY, BY REGION, 2021-2030 ($MILLION)
- TABLE 7. NEUROMONITORING DEVICES MARKET FOR NEAR INFRARED SPECTROSCOPY, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 8. NEUROMONITORING DEVICES MARKET SIZE, FOR SPECKLE IMAGING, BY REGION, 2021-2030 ($MILLION)
- TABLE 9. NEUROMONITORING DEVICES MARKET FOR SPECKLE IMAGING, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 10. NEUROMONITORING DEVICES MARKET SIZE, FOR DOPPLER ULTRASOUND, BY REGION, 2021-2030 ($MILLION)
- TABLE 11. NEUROMONITORING DEVICES MARKET FOR DOPPLER ULTRASOUND, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 12. NEUROMONITORING DEVICES MARKET SIZE, FOR EEG, BY REGION, 2021-2030 ($MILLION)
- TABLE 13. NEUROMONITORING DEVICES MARKET FOR EEG, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 14. NEUROMONITORING DEVICES MARKET SIZE, FOR FETAL/NEONATAL NEURO-MONITORING DEVICES, BY REGION, 2021-2030 ($MILLION)
- TABLE 15. NEUROMONITORING DEVICES MARKET FOR FETAL/NEONATAL NEURO-MONITORING DEVICES, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 16. NEUROMONITORING DEVICES MARKET SIZE, FOR MICRO ULTRASOUND, BY REGION, 2021-2030 ($MILLION)
- TABLE 17. NEUROMONITORING DEVICES MARKET FOR MICRO ULTRASOUND, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 18. NEUROMONITORING DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2030 ($MILLION)
- TABLE 19. NEUROMONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 20. NEUROMONITORING DEVICES MARKET, BY REGION, 2021-2030 ($MILLION)
- TABLE 21. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 22. NORTH AMERICA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 23. U.S. NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 24. CANADA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 25. MEXICO NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 26. EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 27. EUROPE NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 28. GERMANY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 29. UNITED KINGDOM NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 30. FRANCE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 31. SPAIN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 32. ITALY NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 33. REST OF EUROPE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 34. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 35. ASIA-PACIFIC NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 36. CHINA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 37. JAPAN NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 38. INDIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 39. SOUTH KOREA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 40. AUSTRALIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 41. REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 42. LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 43. LAMEA NEUROMONITORING DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
- TABLE 44. BRAZIL NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 45. SAUDI ARABIA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 46. UAE NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 47. SOUTH AFRICA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 48. REST OF LAMEA NEUROMONITORING DEVICES MARKET, BY PRODUCT, 2021-2030 ($MILLION)
- TABLE 49.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 50.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 51.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 52.KONINKLIJKE PHILIPS N.V.: NET SALES,
- TABLE 53.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
- TABLE 54.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
- TABLE 55.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
- TABLE 56.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
- TABLE 57.NIHON KOHDEN CORPORATION: NET SALES,
- TABLE 58.NIHON KOHDEN CORPORATION: KEY STRATERGIES
- TABLE 59.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
- TABLE 60.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
- TABLE 61.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
- TABLE 62.NATUS MEDICAL INCORPORATED: NET SALES,
- TABLE 63.NATUS MEDICAL INCORPORATED: KEY STRATERGIES
- TABLE 64.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 65.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 66.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 67.MEDTRONIC PLC: NET SALES,
- TABLE 68.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 69.GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 70.GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 71.GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 72.GE HEALTHCARE: NET SALES,
- TABLE 73.GE HEALTHCARE: KEY STRATERGIES
- TABLE 74.NUVASIVE, INC.: COMPANY SNAPSHOT
- TABLE 75.NUVASIVE, INC.: OPERATING SEGMENTS
- TABLE 76.NUVASIVE, INC.: PRODUCT PORTFOLIO
- TABLE 77.NUVASIVE, INC.: NET SALES,
- TABLE 78.NUVASIVE, INC.: KEY STRATERGIES
- TABLE 79.ADVANCED BRAIN MONITORING, INC.: COMPANY SNAPSHOT
- TABLE 80.ADVANCED BRAIN MONITORING, INC.: OPERATING SEGMENTS
- TABLE 81.ADVANCED BRAIN MONITORING, INC.: PRODUCT PORTFOLIO
- TABLE 82.ADVANCED BRAIN MONITORING, INC.: NET SALES,
- TABLE 83.ADVANCED BRAIN MONITORING, INC.: KEY STRATERGIES
- TABLE 84.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: COMPANY SNAPSHOT
- TABLE 85.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: OPERATING SEGMENTS
- TABLE 86.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: PRODUCT PORTFOLIO
- TABLE 87.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: NET SALES,
- TABLE 88.INTRANERVE NEUROSCIENCE HOLDINGS, LLC: KEY STRATERGIES
- TABLE 89.RIMED LTD.: COMPANY SNAPSHOT
- TABLE 90.RIMED LTD.: OPERATING SEGMENTS
- TABLE 91.RIMED LTD.: PRODUCT PORTFOLIO
- TABLE 92.RIMED LTD.: NET SALES,
- TABLE 93.RIMED LTD.: KEY STRATERGIES
- TABLE 94.SPECIALTYCARE: COMPANY SNAPSHOT
- TABLE 95.SPECIALTYCARE: OPERATING SEGMENTS
- TABLE 96.SPECIALTYCARE: PRODUCT PORTFOLIO
- TABLE 97.SPECIALTYCARE: NET SALES,
- TABLE 98.SPECIALTYCARE: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.NEUROMONITORING DEVICES MARKET SEGMENTATION
- FIGURE 2.NEUROMONITORING DEVICES MARKET,2021-2030
- FIGURE 3.NEUROMONITORING DEVICES MARKET,2021-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.NEUROMONITORING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.REGULATORY GUIDELINES
- FIGURE 13.VALUE CHAIN ANALYSIS
- FIGURE 14.MARKET SHARE ANALYSIS
- FIGURE 15.KEY REGULATION ANALYSIS
- FIGURE 16.PATENT ANALYSIS BY COMPANY
- FIGURE 17.PATENT ANALYSIS BY COUNTRY
- FIGURE 18.NEUROMONITORING DEVICES MARKET,BY PRODUCT,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INTRACRANIAL PRESSURE MONITORING NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CEREBRAL OXIMETER NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF NEAR INFRARED SPECTROSCOPY NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF SPECKLE IMAGING NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DOPPLER ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF EEG NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF FETAL/NEONATAL NEURO-MONITORING DEVICES NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 26.COMPARATIVE SHARE ANALYSIS OF MICRO ULTRASOUND NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS NEUROMONITORING DEVICES MARKET,2021-2030(%)
- FIGURE 28.NEUROMONITORING DEVICES MARKET BY REGION,2021
- FIGURE 29.U.S. NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 30.CANADA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 31.MEXICO NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 32.GERMANY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 33.UNITED KINGDOM NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 34.FRANCE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 35.SPAIN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 36.ITALY NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 37.REST OF EUROPE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 38.CHINA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 39.JAPAN NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 40.INDIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 41.SOUTH KOREA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 42.AUSTRALIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 43.REST OF ASIA PACIFIC NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 44.BRAZIL NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 45.SAUDI ARABIA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 46.UAE NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 47.SOUTH AFRICA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 48.REST OF LAMEA NEUROMONITORING DEVICES MARKET,2021-2030($MILLION)
- FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 53.COMPETITIVE DASHBOARD
- FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 55.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
- FIGURE 56.NIHON KOHDEN CORPORATION.: NET SALES ,($MILLION)
- FIGURE 57.NATUS MEDICAL INCORPORATED.: NET SALES ,($MILLION)
- FIGURE 58.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 59.GE HEALTHCARE.: NET SALES ,($MILLION)
- FIGURE 60.NUVASIVE, INC..: NET SALES ,($MILLION)
- FIGURE 61.ADVANCED BRAIN MONITORING, INC..: NET SALES ,($MILLION)
- FIGURE 62.INTRANERVE NEUROSCIENCE HOLDINGS, LLC.: NET SALES ,($MILLION)
- FIGURE 63.RIMED LTD..: NET SALES ,($MILLION)
- FIGURE 64.SPECIALTYCARE.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook